Advances in the Management of Metastatic Breast Cancer with SABCS Updates
With expanding treatment options, clinicians are challenged to understand important criteria used in selecting optimal first- and subsequent-line therapies for individuals with metastatic breast cancer. Staying up-to-date with the available treatment options is important to integrate new evidence-based data into their clinical practice, and being familiar with their toxicity profiles is important to optimize patient outcomes.
Category
- Breast Cancer
Format
- Recorded Webcast
Credits
- 1.25 AAPA Category 1 CME credit
- 1.25 ACPE contact hours
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC contact hours
- 1.25 Participation
Operational Excellence for Inpatient Rounding
As quality measures are set by governing bodies to reflect reimbursement, institutions not only have to be fiscally responsible but at the same time responsible for improving quality of care. Multidisciplinary engagement and buy-in are essential in this quest.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Early Involvement of Palliative Care in Cancer Treatment
The early involvement of palliative care can help address and treat these other aspects of cancer, improving the patient’s quality of life and, in some cases, outcomes. Too often, palliative care is instituted late in the disease trajectory, if at all, which can lead to unnecessary suffering on the part of patients and caregivers.
Category
- Palliative Care
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
New Challenges in the Management of Pulmonary Toxicities
Pulmonary function is important to maintaining homeostasis and dysfunction can result in life-threatening complications. There is a need to discuss the incidence, prevention, and management of pulmonary toxicities given that numerous cancer treatments have the potential to cause pulmonary dysfunction. Clinician education on this topic can help them provide optimal care for patients experiencing pulmonary toxicity.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Updates in Biomarker Testing in Non-Small Cell Lung Cancer
Biomarker testing is becoming more important due to the shift in cancer care to targeted therapies. Especially in NSCLC, there are many new updates in which biomarkers should be tested, when testing is required or recommended, and what the barriers are to implementing testing for all patients.
Category
- Lung Cancers
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Management of Acute Hyperglycemia
Hyperglycemia is a common complication of cancer and its treatments. Appropriate monitoring and management of hyperglycemia is critical to prevent glycemic emergencies and optimize response to chemotherapy.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Harm Reduction Strategies for Substance Use in Patients with Cancer
Patients with cancer are at risk of substance use disorder (SUD), which is commonly misunderstood and inappropriately managed. Understanding the basis of addiction and applying harm reduction principles to patients living with SUD presents an opportunity to enhance patient care.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Providing Access to Cancer Care in Historically Marginalized Communities: Lessons Learned from Dana-Farber’s Cancer Care Equity Program
Disparities in cancer care in historically marginalized communities have been well documented. Identification of patients at risk for health inequity and strategies to mitigate disparities can help address current practice gaps in historically marginalized communities.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Management of Central Nervous System Metastases
As a result of advances in diagnosis and treatment, many patients improve with proper management and do not die of progression of these metastatic lesions. As CNS-active systemic agents are changing paradigms for the management of brain metastases, it is important to acknowledge that there is a paucity of prospective data to characterize optimal strategies regarding radiation and systemic therapy combinations or sequencing.
Category
- Central Nervous System Cancers
- Central Nervous System Cancers
Format
- Recorded Webcast
Credits
- 0.75 AAPA Category 1 CME credit
- 0.75 ACPE contact hours
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC contact hours
- 0.75 Participation
The Art of Creating and Sustaining Interprofessional Teams to Provide Comprehensive Care Throughout the Patient Journey
Clinicians need to be educated on the vast and varied impact cancer can have on individuals, the barriers to receipt of high-quality care, and the various professionals who can be part of their team to provide comprehensive care and improve patient outcomes. Information on approaches to build, maintain, and support such teams is also needed so that patients can benefit.
Category
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation